Institute of Cardiovascular Diseases Prof. Dr. George I.M. Georgescu, 700503 Iasi, Romania.
Faculty of Medicine, University of Medicine and Pharmacy Grigore T Popa, 700115 Iasi, Romania.
Medicina (Kaunas). 2021 May 27;57(6):538. doi: 10.3390/medicina57060538.
cardiovascular complications (CVC) are the leading cause of death in patients with chronic kidney disease (CKD). Standard cardiovascular disease risk prediction models used in the general population are not validated in patients with CKD. We aim to systematically review the up-to-date literature on reported outcomes of computational methods such as artificial intelligence (AI) or regression-based models to predict CVC in CKD patients. the electronic databases of MEDLINE/PubMed, EMBASE, and ScienceDirect were systematically searched. The risk of bias and reporting quality for each study were assessed against transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD) and the prediction model risk of bias assessment tool (PROBAST). sixteen papers were included in the present systematic review: 15 non-randomized studies and 1 ongoing clinical trial. Twelve studies were found to perform AI or regression-based predictions of CVC in CKD, either through single or composite endpoints. Four studies have come up with computational solutions for other CV-related predictions in the CKD population. the identified studies represent palpable trends in areas of clinical promise with an encouraging present-day performance. However, there is a clear need for more extensive application of rigorous methodologies. Following the future prospective, randomized clinical trials, and thorough external validations, computational solutions will fill the gap in cardiovascular predictive tools for chronic kidney disease.
心血管并发症(CVC)是慢性肾脏病(CKD)患者死亡的主要原因。用于一般人群的标准心血管疾病风险预测模型在 CKD 患者中尚未得到验证。我们旨在系统地回顾有关计算方法(如人工智能(AI)或基于回归的模型)报告结果的最新文献,以预测 CKD 患者的 CVC。系统地检索了 MEDLINE/PubMed、EMBASE 和 ScienceDirect 电子数据库。针对透明报告个体预后或诊断的多变量预测模型(TRIPOD)和预测模型风险偏倚评估工具(PROBAST),评估了每项研究的偏倚风险和报告质量。本系统评价纳入了 16 篇论文:15 篇非随机研究和 1 项正在进行的临床试验。有 12 项研究通过单一或复合终点对 CKD 中的 CVC 进行了 AI 或基于回归的预测。有 4 项研究针对 CKD 人群中的其他心血管相关预测提出了计算解决方案。所确定的研究代表了具有临床前景的领域中的明显趋势,目前表现令人鼓舞。然而,非常需要更广泛地应用严格的方法。在未来的前瞻性、随机临床试验和彻底的外部验证之后,计算解决方案将填补慢性肾脏病心血管预测工具的空白。